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Prosthetic valve thrombosis despite
seemingly -adequate anticoagulation:
the dangers of transient lapses in
anticoagulation
Jafary

F

H, Hassan K

ABSTRACT
We report a I9 -year -old woman with
thrombosis of a prosthetic mitral valve that
was most likely due to a short dip in
anticoagulation in the days preceding the event.
Interestingly, at presentation the patient was
super -therapeutic, most likely a result of
hepatic congestion as the heart began to fail,
creating an illusion of thrombosis despite
adequate anticoagulation.

dyspnoea. Physical examination revealed her to be afebrile

and in florid pulmonary oedema. The prosthetic mitral

valve sounds were considerably muffled. White blood cell
counts and subsequent blood cultures were unremarkable.

Transthoracic echocardiography revealed a transmitral

gradient of 28 mmHg with trivial mitral regurgitation.

Immobile
.posterior disc,
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INTRODUCTION
Metallic prosthetic valves are associated with an increased

risk of thrombosis and subsequent embolism. The morbidity
and mortality associated with prosthetic valve thrombosis

restricted -;,
anterior disc

(PVT) is substantial. This risk is significantly greater with

valves in the mitral position, probably owing to lower
velocities of blood flow. Meticulous anticoagulation with

warfarin reduces this risk considerably to approximately

Fig. I Fluoroscopic image of mitral valve shows immobile and
restricted leaflets.

0.2 per patient-year.(') Most cases of PVT reported in the

literature are associated with consistently inadequate
anticoagulation. However, there is no data on the dangers
of transient lapses in the level of anticoagulation. We report
Department of

on a case of PVT occurring three months after implantation
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with super -therapeutic anticoagulation at presentation, but

i

a short "dip" in levels in the days preceding the event.
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CASE REPORT
A 19 -year -old woman underwent mitral valve replacement
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with a CarboMedicsTM bileaflet mechanical valve for mitral
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regurgitation three months prior to admission. Her
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normalised ratio (INR) at discharge was 3.2. 15 days prior
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to admission, her INR decreased to 1.9, following which

Dr Fahim H Jafary
Tel: (92) 21 486 4700
Fax: (92) 21 493 4294
Email: jafary@pobox.
corn

the dose of warfarin was increased. Five days prior to

Fig. 2 Photograph shows the excised mitral valve laden with

admission, she developed progressively worsening

thrombus.
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A transoesophageal echocardiogram (TEE) confirmed the

suboptimal anticoagulation 15 days prior to admission

above findings and suggested that the posterior mitral valve

(INR 1.9) may have resulted in a nidus of thrombus forming

disc was immobile. No vegetations were seen. At

on the valve, eventually culminating in valve thrombosis.

fluoroscopy, the anterior disc was noted to have limited

The super-therapeutic levels of anticoagulation observed

excursion and the posterior disc was immobile (Fig. 1).

at presentation may simply have been a consequence of

One day prior to admission, the patient's INR was 4.6. The

hepatic congestion secondary to a failing heart, providing

patient underwent emergency replacement of her mitral
valve, this time with a bioprosthesis. Perioperatively, the

the illusion that this patient developed PVT despite being

valve was laden with thrombus with severe restriction of

there was no prior history of any hypercoagulable state.

both discs (Fig. 2). She has remained well since.

It is unclear why our patient's anticoagulation levels dropped

well-anticoagulated. Although not formally worked up,

initially. As far as we can ascertain, there were no interacting

DISCUSSION

drugs in her history nor was there an obvious dietary cause.

Thrombosis is an uncommon yet serious complication after

In conclusion, PVT can occur as a consequence of

valve replacement with a mechanical prosthesis. The clinical

transient dips in anticoagulation level. This case highlights

presentation can range from subtle embolic events to florid

the dangers of failing to maintain adequate anticoagulation

pulmonary oedema and cardiogenic shock. PVT should

in patients with metallic prosthetic valves, even for relatively

be suspected with any deterioration in clinical status or

short durations. This is particularly true for developing

with thromboembolic complications. TEE and fluoroscopy

countries where rheumatic valvular heart disease is very

can reliably evaluate leaflet mobility and help in diagnosis

common and meticulous anticoagulation is logistically

as well as follow-up of response to treatment.lzl Therapy

difficult.

includes infusion of a thrombolytic agent for 27-72 hours,
with or without heparin, and aspirin131 or surgery.l41 Long-
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